首頁
瀏覽量: 128
- 產品名稱： Anti SARS-CoV-2(2019-nCoV) South Africa spike variant Neutralizing antibody(B.1.351)
- 產品貨號： CSMA10330Mo
- 貨期： 現(xiàn)貨
- 價格與訂購： 2880
- 數(shù)量：
庫存： 100
- 規(guī)格：
- 產品信息
- 如何訂購
產品名稱（Product name）
Anti SARS-CoV-2(2019-nCoV) South Africa spike variant Neutralizing antibody(B.1.351)
貨號（Catalog#）
CSMA10330Moicon
描述（description）
Recombinant anti SARS-CoV-2(2019-nCoV) South Africa spike variant Neutralizing antibody(B.1.351) is expressed from XtenCHO
iconiconicon
別名（Alternative names)
Anti Spike glycoprotein antibody
穩(wěn)定性&儲存（Stability &Storage）
Use a manual defrost freezer and avoid repeated freeze thaw cycles.
Store at 2 to 8 °C for one week .
Store at -20 to -80 °C for twelve months from the date of receipt.
特異性（Spcificty）
Recognizes SARS-CoV-2(2019-nCoV) South Africa spike variant Protein
亞型（Isotype）
Human IgG
克隆性（Clonality）
Monoclonal
偶連物（Conjugation）
Unconjugate
種屬反應性（Species reactivity）
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
應用實驗（Tested applications）
WB,ELISAiconiconicon
免疫原（Immunogen）
Recombinant SARS-CoV-2(2019-nCoV) South Africa spike variant protein
背景（Background）
Cleavage by the viral main protease, 3CLpro results in generating the nsp8 protein, The nsp8 protein has been shown to associate with several other nsps and to colocalize with these nsps in cytoplasmic complexes that are important for viral RNA synthesis. It forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, may synthesize substantially longer products than oligonucleotide primers. Nsp8 was shown to have RNA-dependent RNA polymerase (RdRp) activity that could be involved in producing primers utilized by nsp12 which is normally accepted to be the RdRp for SARS-CoV.icon
狀態(tài)（Form）
Liquidicon
儲存溶液（Buffer）
PBS,pH7.5
iconicon
應用實驗及稀釋比例（Dilution Range）
WB:1:1000-2000; ELISA:1:5000-1:10000
iconicon
iconicon
Note
For research use only .
地 址：
產品銷售：
E - mail ：
郵 編：
Amily
